Interrelation between mTB multi drug-resistance and cytokine activity in pulmonary TB patients and mTB virulence

L. Surkova, N. Shpakovskaya, A. Zalutskaya, A. Skrahina, Z. Rohava (Minsk, Belarus)

Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Session: Clinical immunology of tuberculosis
Session type: Thematic Poster Session
Number: 2577
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Surkova, N. Shpakovskaya, A. Zalutskaya, A. Skrahina, Z. Rohava (Minsk, Belarus). Interrelation between mTB multi drug-resistance and cytokine activity in pulmonary TB patients and mTB virulence. Eur Respir J 2009; 34: Suppl. 53, 2577

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of cytokines in the immunopathogenesis of the MDR pulmonary tuberculosis
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008

The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

Antituberculous activity of fiurenizid in vitro and in patients with destructive pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 724s
Year: 2004

Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR)
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009


Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Drug resistance patterns in patients with multi-drug resistant tuberculosis (MDR – TB)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012


Prevalence of pulmonary tuberculosis in spinal tuberculosis patients
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017


Cytokine gene polymorphisms and mycobacterium tuberculosis: from infection to pulmonary disease
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006


Primary drug resistance in pulmonary tuberculosis
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


The significance of the antigen-specific IFN-γ release assay in vitro for differential diagnosis between sarcoidosis and tuberculosis (TB) patients
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010

Peculiarities and results of treatment in XDR pulmonary tuberculosis (PTB)
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008


IFN-γ response on T-cell based assays for the diagnosis of tuberculosis infection in rheumatic patients undergoing anti-TNF-α treatment
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Structure of drug resistance of M. tuberculosis in children and adolescents with pulmonary TB
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002

Outcome of zinc & vit-A supplementation in the treatment multidrug resistance pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010